[1] Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol, 2013, 10: 307-318.
[2] Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol, 2006, 40: 745-752.
[3] Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol, 2013 28: Suppl 111-117.
[4] Fan JG, Cao HX. Role of diet and nutritional management in non-alcoholic fatty liver disease. J Gastroenterol Hepatol, 2013, 28: Suppl 481-487.
[5] Assy N,Nasser G,Kamayse I,et al.Soft drink-consumption linked with fatty liver in the absence of traditional risk factors.Can J Gastroenterol,2008,22:811-816.
[6] Wang Z,KlJipfel E,Bennett BJ,et al.Gut flora metabolism of phosphatidylcho-line promotes cardiovascular disease.Nature,2011,472:57-63.
[7] Hartiala J,Bennett BJ,Tang WH,et al.Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide,aproatherogenic metabolite of choline and L—carnitine.Arterioseler Thromb Vasc Biol,2014,34:1307-1313.
[8] Hartiala J,Bennett BJ,Tang WH,et al.Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide,a proatherogenic metabolite of choline and L-carnitine.Arterioscler Thromb Vasc Biol,2014,34:1307-1313.
[9] Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 2011, 472: 57-63.
[10] Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med, 2013, 368: 1575-84.
[11] 王珊,夏耿红,何彦,等. 氧化三甲胺分布特征及其与肠道菌群的关联性.南方医科大学学报,2016,36: 455-460.
[12] 王珊. 不同人群血液氧化三甲胺水平与肠道菌群关联分析. 南方医科大学, 2016.
[13] Fennema D, Philips IR, Shephard EA. Trimethyl-amine and trimethylamine N-oxide,a flavincontaining monoox-ygenase 3 (FM03)-mediated host-microbiome metabolic axis implicated in health and disease.Drug Metab Dispos,2016,44:1839-1850.
[14] Koeth RA. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med, 2013, 19: 576-585.
[15] 廖沛球, 魏来, 刘威,等. 给药硝酸钕后大鼠完整肝组织及肝组织提取物的NMR代谢组学研究. 高等学校化学学报, 2009, 30: 1116-1120.
[16] Dumas ME, Barton RH, Toye A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.Proc Natl Acad Sci USA,2006, 103: 12511-12516.
[17] Gao X, Liu X, Xu J, et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng, 2014, 118: 476-481.
[18] 刘燕. 胆碱肠道菌群依赖代谢物-氧化三甲胺与非酒精性脂肪肝病的关系. 中国营养学会.中国老龄化与健康高峰论坛论文汇编. 中国营养学会: 2014: 2.
[19] Chen YM, Yan L, Zhou RF, et al. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. Sci Rep, 2016, 6:19076. |
